If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure
Funding round led by Sarissa Capital, includes Sun Pharma, Polaris Partners
The transfer of the distribution rights will strengthen Sandoz's immunology and biosimilar portfolio
Ami Organics will also sign an MoU with Government of Gujarat for investment amounting up to Rs 300 crores for set up of dedicated manufacturing facility for electrolytes business
Trinity has availed credit facility from Investec for Business for their working capital requirements of Rs. 31.5 crore
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024
The commissioning of the facility represents the culmination of a £45m investment to address rapidly growing demand for ADC manufacturing, supported by a £2.4m Scottish Enterprise grant
Development services for gene and cell therapies is planned to begin first in 2025
Clariant Healthcare highlighted Vitipure Meglumine LEX and VitiPure Superior at the recently concluded CPhI India
Subscribe To Our Newsletter & Stay Updated
